Phase I study of 225Ac-J591 for men with metastatic castration-resistant prostate cancer (mCRPC).

Scott T. Tagawa,Michael Sun,A. Oliver Sartor,Charlene Thomas,Sharon Singh,Mahelia Bissassar,Escarleth Fernandez,Muhammad Junaid Niaz,Benedict Ho,Shankar Vallabhajosula,John W. Babich,Ana M. Molina,Cora N. Sternberg,David M. Nanus,Joseph R. Osborne,Neil H. Bander

Journal of Clinical Oncology（2021）

引用 22|浏览1

暂无评分

摘要

5015Background: Antibodies and small molecule ligands target PSMA with different kinetics and biodistribution, with certain sites of PSMA expression such as salivary/lacrimal glands, kidneys, and s...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要